A 26-year-old male complained of fever, right neck swelling, anorexia, and weight loss for 4 months. The patient noticed a right swelling in the root of the neck that progressed from 1 × 1 cm to 5 × 6 cm. We reported a Kikuchi-like acute lymphoblastic leukemia (ALL) case. Three 3 × 3 cm lymph nodes were found in the right cervical area at IIB and III levels, firm, mobile, and nontender. Petechiae and purpura on the left upper limb, wet purpura on the palate, a positive Hess test, and temperature spikes were present. The patient is responding well to ALL treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11888683 | PMC |
| http://dx.doi.org/10.4103/jpbs.jpbs_1208_24 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Leukemia's Wake-Up Call - A Case Report of a Patient's Journey.
J Pharm Bioallied Sci
December 2024
Department of General Medicine, Pushpagiri Institute of Medical Sciences and Research Centre, Tiruvalla, Kerala, India.
A 26-year-old male complained of fever, right neck swelling, anorexia, and weight loss for 4 months. The patient noticed a right swelling in the root of the neck that progressed from 1 × 1 cm to 5 × 6 cm. We reported a Kikuchi-like acute lymphoblastic leukemia (ALL) case.
View Article and Find Full Text PDFPlace of care manufacturing of chimeric antigen receptor cells: Opportunities and challenges.
Semin Hematol
January 2023
The Ohio State University, Columbus, OH.
The landscape of therapeutic options for B cell malignancies has fundamentally changed with regulatory and marketing approval of chimeric antigen receptor (CAR)-engineered T cell products. The cell types used for CAR-T production, the length of time of manufacture, the stimulation matrix, and the nature of the gene vector used to transduce human T cells all are significant variables that require adequate quality control before infusion. Having approved products available to clinicians using a centralized production paradigm has not stopped innovation in investigator-initiated trials.
View Article and Find Full Text PDFPoorer Clinical Outcomes for Black Patients with AML: A Wake-Up Call for Better Data and Greater Understanding of Cancer Outcomes in All Ethnic Groups.
Cancer Discov
March 2021
MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford NIHR Biomedical Research Centre, and Oxford University Hospitals NHS Trust, Oxford, UK.
In this issue of , Bhatnagar and colleagues show that Black patients in the United States with acute myeloid leukemia have a shorter survival compared with white patients. This is an important paper as it addresses an under researched issue: the complex interaction of race, tumor genetics, socioeconomic factors, and access to treatment in defining treatment outcomes for a devastating cancer..
View Article and Find Full Text PDFAML Therapy: Wake Up the Guardian and Cut Loose the Executioners.
Cancer Cell
December 2017
Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104, USA. Electronic address:
In this issue of Cancer Cell, Pan et al. show that a combination therapy designed to reactivate the p53 tumor suppressor while antagonizing the anti-apoptotic function of Bcl-2 is highly active in preclinical models of refractory acute myeloid leukemia (AML). The results may move the needle in this hard-to-treat malignancy.
View Article and Find Full Text PDFTo wake up cancer stem cells, or to let them sleep, that is the question.
Cancer Sci
July 2016
Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Cancer stem cells (CSCs) generate transient-amplifying cells and thereby contribute to cancer propagation. A fuller understanding of the biological features of CSCs is expected to lead to the development of new anticancer therapies capable of eradicating this life-threatening disease. Cancer stem cells are known to maintain a non-proliferative state and to enter the cell cycle only infrequently.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!